Conformis Pivots to Standard Knees Amid ASC Growth
The company mitigated substantial product revenue losses in 2Q20 through a royalty payment from Zimmer Biomet to settle a patent infringement dispute. Aug 07, 2020
Globus Medical’s Growth Continues to Outpace Peers
The company exited 2Q20 with double-digit growth that accelerated to the mid-teens in July as new products and competitive rep hiring drove share gains. Aug 07, 2020
NuVasive Does Not Expect Full Recovery in 2020
The company believes patient backlogs contributed significantly to volume acceleration observed in 2Q20, while new patient volumes remain depressed. Aug 06, 2020
Zimmer Biomet to Focus on High-Growth Businesses
A quicker than expected market recovery mitigated COVID's impact on the company's 2Q20 revenue as Zimmer Biomet shifts its focus to high-growth segments. Aug 05, 2020
SI-BONE Churns Through Procedure Backlog in 2Q
The company exited June 2020 with revenues up +42% compared to the prior year as it benefitted from a backlog of procedures rescheduled in March and April. Aug 05, 2020
Anika Inorganic Growth Offsets COVID Declines
Sports medicine revenue from the acquisition of Parcus Medical and Arthrosurface helped Anika navigate the low point of the COVID orthopedic market in 2Q20. Aug 03, 2020
Stryker’s Mako Growth Strong Despite Hospital Constraints
While the company’s orthopedic segments continue to recover from the April low point, the Mako robotic system continued its strong growth trend in 2Q20. Aug 03, 2020
Seikagaku International Sales Tumble Amid COVID Surge
The company's international viscosupplement sales declined by nearly -40% in 2Q20 as COVID continues to spread in Seikagaku's key U.S. market. Jul 31, 2020
Smith+Nephew Prepared to Capitalize on ASC Acceleration
The company's orthopedic sales fell -34% in 2Q20, but Smith+Nephew is strategically positioned to benefit from the acceleration in ASC procedures. Jul 31, 2020
Amplitude Prepared to Endure Second Wave of Pandemic
Amplitude's sales fell nearly -14% for their fiscal year 2020 due to COVID-19, but the company's foot and ankle products still managed double-digit growth. Jul 27, 2020
